- The trend backdrop is active with a 7-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
6696
TWO
Week ended 14 Aug 2026
Weekly Investor Report
Lin BioScience, Inc. · Healthcare · Biotechnology
Latest close
912.0 TWD
30.7%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 98.0% above the Trend Line and sits at 97.7% of its 52-week range. The latest completed week returned 30.7%, after a 30.7% four-week move. Near-term considerations: price is close to its 52-week high.
Setup score
74
out of 100
Latest Close
912.0 TWD
14 Aug 2026
1W Return
30.7%
latest completed week
4W Return
30.7%
short-term follow-through
12W Return
131.8%
quarterly tape
Trend Breadth
98.1%
51 of 52 weeks active
Volume Ratio
2.2x
vs 13-week average
- Next-week expectancy is negative at 44.49% based on similar historical setup states.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
30.7%
Latest completed week; four-week move 30.7%.
Indicator stack
78/87
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 44.49%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 98.0% above the Trend Line and sits at 97.7% of its 52-week range. The latest completed week returned 30.7%, after a 30.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.2x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.7712-week average 0.67
12-week confirmation
Trend active11/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership7/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.77Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 30.7% over four weeks, 131.8% over 12 weeks, and 463.0% over one year. The current trend has remained active for 7 consecutive weeks.
Performance by holding period
Active trend streak7 weeks
Active weeks in one year51
Trend breadth98.1%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.72Latest activity-pressure read.
Pressure change74.7%Four-week change in activity pressure.
Leadership80.96Latest relative-leadership reading.
RS change33.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment-
No current sentiment snapshot is stored.
Patient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-1.9%Distance below the 52-week high.
13-week volatility12.2%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
20 Mar
17 Apr
15 May
12 Jun
10 Jul
14 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+31.7%Week of 10 Jul.
Worst week-5.3%Week of 31 Jul.
Latest week+30.7%Week of 14 Aug.
Shape of recent returns
Strong gains7
Modest gains6
Flat weeks0
Modest losses10
Sharp losses3
Recent vol12.2%13-week weekly-return volatility.
Base vol11.8%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew11.1% / -3.8%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank1 / 100
Group average0.1%
Trend breadth34.0%
Trend34.0%active weekly trend signals
MD60.0%positive activity pressure
RS9.0%positive relative leadership
Four-week leaders
IndustryTW Biotechnology
4-week rank1 / 96
Group average-2.7%
Trend breadth24.0%
Trend24.0%active weekly trend signals
MD39.6%positive activity pressure
RS6.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape71/100
Trend, activity pressure, participation, and risk combine to a 71/100 tape read.
Indicator analysis67/100Latest 12-week confirmation: trend 11/12, activity pressure 6/12, relative leadership 7/12.
Activity pressure 0.77; No reversal markers Next-Week ExpectancyNegative 44.49%Next-week expectancy is negative with a 44.49% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100No sentiment snapshot is stored yet.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 14 Aug 2026 | 912.0 TWD | 30.7% | 460.7 TWD | 206.0 TWD | 1.72 | 80.96 | 11.3M | On |
| 7 Aug 2026 | 698.0 TWD | 2.5% | 442.5 TWD | 200.9 TWD | 1.72 | 46.84 | 5.9M | On |
| 31 Jul 2026 | 681.0 TWD | -5.3% | 432.4 TWD | 197.3 TWD | 1.82 | 49.44 | 7.4M | On |
| 24 Jul 2026 | 719.0 TWD | 3.0% | 422.9 TWD | 193.7 TWD | 1.64 | 58.52 | 6.0M | On |
| 17 Jul 2026 | 698.0 TWD | 12.4% | 412.5 TWD | 189.8 TWD | 0.99 | 60.48 | 8.5M | On |
| 10 Jul 2026 | 621.0 TWD | 31.7% | 402.5 TWD | 186.1 TWD | 0.29 | 36.97 | 10.5M | On |
| 3 Jul 2026 | 471.5 TWD | 19.5% | 395.7 TWD | 182.9 TWD | -0.43 | 2.31 | 5.6M | On |
| 26 Jun 2026 | 394.5 TWD | -1.9% | 394.7 TWD | 180.8 TWD | -0.88 | -9.43 | 1.6M | Off |
| 19 Jun 2026 | 402.0 TWD | 3.6% | 391.3 TWD | 179.2 TWD | -0.98 | -10.96 | 1.2M | On |
| 12 Jun 2026 | 388.0 TWD | -2.9% | 387.1 TWD | 177.5 TWD | -1.05 | -9.15 | 1.6M | On |
| 5 Jun 2026 | 399.5 TWD | 6.2% | 383.9 TWD | 176.0 TWD | -0.96 | -7.90 | 2.4M | On |
| 29 May 2026 | 376.0 TWD | -4.4% | 379.4 TWD | 174.4 TWD | -0.92 | -12.23 | 2.4M | On |
| 22 May 2026 | 393.5 TWD | -1.4% | 376.7 TWD | 173.0 TWD | -0.74 | -2.41 | 1.5M | On |
| 15 May 2026 | 399.0 TWD | 2.6% | 372.4 TWD | 171.4 TWD | -0.33 | 2.16 | 2.5M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.